Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Visto.bio is a Brazilian biotechnology company founded in 2014 that specializes in applying biological solutions to personal care and sustainability. The company's core technology focuses on balancing the skin's natural microbiota to eliminate body odor at its source, rather than masking it with traditional chemicals like aluminum or parabens. Their flagship products, including Visto.bio Original and Antisséptico, are designed to strengthen protective microorganisms on the skin and can also be applied to textiles to prevent bacterial growth. Recognized for its innovative approach to hygiene, the company has expanded into a direct-to-consumer model and established partnerships across the retail and fashion sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Visto.